Press Releases - 2022-10-10

Date	Title	Company
10-Oct-2022	Chemours Announces Joint Venture Agreement with BWT to Enable the Capacity and Innovation Required by the Transportation Fuel Cell Market	Businesswire
10-Oct-2022	Ochre Bio Raises $30M Series A Financing for the Development of RNA Therapies for Chronic Liver Diseases	Businesswire
10-Oct-2022	Revance to Present Clinical Data on the Efficacy and Safety Profile of DAXXIFY™ (DaxibotulinumtoxinA-lanm) for Injection at the 2022 American Society for Dermatologic Surgery (ASDS) Annual Meeting	Businesswire
10-Oct-2022	Charles River Launches nAAVigation Vector Platform to Accelerate Gene Therapy Programs	Businesswire
10-Oct-2022	Ray Therapeutics and Forge Biologics Expand Their Viral Vector cGMP Partnership to Encompass Plasmid DNA Manufacturing	Businesswire
10-Oct-2022	Rocket Pharmaceuticals to Present at the 2022 Cell & Gene Meeting on the Mesa	Businesswire
10-Oct-2022	IconOVir Bio Appoints Julia Maltzman, M.D., as Chief Medical Officer	Businesswire
10-Oct-2022	CommScope Launches the HomeSight™ System for Healthcare and Homecare & Announces First Partnership with Kraydel to Deliver Innovative Solutions for this Market	Businesswire
10-Oct-2022	Merck Recognized on Fortune’s 2022 Change the World List for Expanding Access to HPV Vaccines	Businesswire
10-Oct-2022	Global Budesonide Inhaler Market to Reach $377.45 Million by 2027 at a 9.16% CAGR - ResearchAndMarkets.com	Businesswire
10-Oct-2022	Growth Opportunities in Supply Chain Monitoring, Vaccine Development, COVID Diagnosis, and Wireless Charged Wearable Devices - ResearchAndMarkets.com	Businesswire
10-Oct-2022	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
10-Oct-2022	HUTCHMED Initiates a Phase II/III Trial of Sovleplenib for Warm Antibody Autoimmune Hemolytic Anemia in China	HUTCHMED
10-Oct-2022	New toolkit launched to help navigate medicines repurposing	LifeArc and the Medical Research Council (MRC)
10-Oct-2022	New Preclinical Data on CNS Programs to be presented at European Society of Gene & Cell Therapy Congress 2022 and International Symposium on NBIA	Bloomsbury Genetic Therapies Limited
10-Oct-2022	Global Irritable Bowel Syndrome Market to Grow by $779.89 Million Through 2025 - ResearchAndMarkets.com	Businesswire
10-Oct-2022	BELLUS Health to Present Clinical Data from Phase 2b SOOTHE Trial of BLU-5937 at the CHEST Annual Meeting	Businesswire
10-Oct-2022	Bicycle Therapeutics Announces Publication of Article in the Journal of Medicinal Chemistry Highlighting Preclinical Data from BT8009 Program	Businesswire
10-Oct-2022	Brainomix Announces Collaboration with UK Government-Funded NCIMI to Evaluate AI-Powered Technology in Lung Cancer Care	Brainomix
10-Oct-2022	NovaBay Pharmaceuticals’ Avenova® and DERMAdoctor® Products to be Featured During the October 11-12 Amazon Prime Early Access Sale	Businesswire